Reply: To PMID 25865049.
作者信息
Vilar-Gomez Eduardo, Friedman Scott L, Romero-Gomez Manuel
机构信息
Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba; Unit for the Clinical Management of Digestive Diseases, Virgen del Rocio University Hospital University of Seville, Seville, Spain; Institute of Biomedicine of Seville (IBIS), Seville, Spain.
Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York.
出版信息
Gastroenterology. 2015 Dec;149(7):1988-9. doi: 10.1053/j.gastro.2015.10.040. Epub 2015 Oct 26.
PMID:26515488
Abstract
摘要
相似文献
1
Reply: To PMID 25865049.回复：致医学主题标识符25865049。
Gastroenterology. 2015 Dec;149(7):1988-9. doi: 10.1053/j.gastro.2015.10.040. Epub 2015 Oct 26.
2
[Weight loss can cure fatty liver].减肥可以治愈脂肪肝。
MMW Fortschr Med. 2015 Sep 24;157(16):38.
3
Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis.低碳水化合物而非低脂饮食在非酒精性脂肪性肝炎的饮食管理中更为重要。
Gastroenterology. 2015 Dec;149(7):1987-8. doi: 10.1053/j.gastro.2015.09.044. Epub 2015 Oct 26.
4
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.通过生活方式改变减轻体重可显著改善非酒精性脂肪性肝炎的特征。
Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5. doi: 10.1053/j.gastro.2015.04.005. Epub 2015 Apr 10.
5
Reply: To PMID 25524401.回复：致PMID 25524401。
Hepatology. 2015 Dec;62(6):1921-2. doi: 10.1002/hep.28030. Epub 2015 Oct 16.
6
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.小儿非酒精性脂肪性肝病：近期的解决方案、未解决的问题及未来研究方向
World J Gastroenterol. 2016 Sep 28;22(36):8078-93. doi: 10.3748/wjg.v22.i36.8078.
7
[Diagnosis and treatment strategy of pediatric nonalcoholic fatty liver disease].[小儿非酒精性脂肪性肝病的诊断与治疗策略]
Zhonghua Er Ke Za Zhi. 2024 Jun 2;62(6):590-592. doi: 10.3760/cma.j.cn112140-20240326-00213.
8
Non-alcoholic fatty liver disease in children.儿童非酒精性脂肪性肝病。
Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):297-300. doi: 10.1016/j.clinre.2012.03.026. Epub 2012 Apr 21.
9
Update on treatment strategies in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者治疗策略的最新进展
Curr Pharm Des. 2013;19(29):5167-8.
10
[Treatment of non-alcoholic fatty liver disease].[非酒精性脂肪性肝病的治疗]
Ned Tijdschr Geneeskd. 2011;155:A3181.
引用本文的文献
1
Fluorofenidone attenuates choline-deficient, l-amino acid-defined, high-fat diet-induced metabolic dysfunction-associated steatohepatitis in mice.氟非尼酮减轻胆碱缺乏、L-氨基酸限定、高脂饮食诱导的小鼠代谢功能障碍相关脂肪性肝炎。
Sci Rep. 2025 Mar 21;15(1):9863. doi: 10.1038/s41598-025-94401-7.
2
Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content.超声衍生的脂肪分数用于检测肝脂肪变性和定量肝脏脂肪含量。
Radiol Med. 2023 Oct;128(10):1174-1180. doi: 10.1007/s11547-023-01693-8. Epub 2023 Aug 12.
3
Effect of Obesogenic Medications on Weight-Loss Outcomes in a Behavioral Weight-Management Program.行为体重管理方案中致肥胖药物对减肥效果的影响。
Obesity (Silver Spring). 2019 May;27(5):716-723. doi: 10.1002/oby.22444.
Zotero 插件